Literature DB >> 15074178

[Genetic research with stored human tissue: a coding procedure with optimal use of information and protection of privacy].

M K Schmidt1, F E van Leeuwen, H M Klaren, R A Tollenaar, L J van 't Veer.   

Abstract

To answer research questions concerning the course of disease and the optimal treatment of hereditary breast cancer, genetic typing together with the clinical and tumour characteristics of breast cancer patients are an important source of information. Part of the incidence of breast cancer can be explained by BRCA1 and BRCA2 germline mutations, which with current techniques can be retrospectively analysed in stored, paraffin-embedded tissue samples. In view of the implications of BRCA1- or BRCA2-carrier status for patients and other family members and the lack of clear legal regulations regarding the procedures to be followed when analysis is performed on historical material and no individual informed consent can be asked from the patients, an appropriate procedure for coding such data or rendering it anonymous is of great importance. By using the coding procedure described in this article, it becomes possible to follow and to work out in greater detail the guidelines of the code for 'Proper secondary use of human tissue' of the Federation of Biomedical Scientific Societies and to use these valuable databases again in the future.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15074178

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  2 in total

1.  The complexities of ethical evaluation of genomics research.

Authors:  R Hoedemaekers; B Gordijn; Y Hekster; F van Agt
Journal:  HEC Forum       Date:  2006-03

2.  Accuracy of BRCA1 and BRCA2 founder mutation analysis in formalin-fixed and paraffin-embedded (FFPE) tissue.

Authors:  M A Adank; E Brogi; F Bogomolniy; E A Wadsworth; K J Lafaro; C J Yee; T Kirchhoff; E J Meijers-Heijboer; N D Kauff; J Boyd; K Offit
Journal:  Fam Cancer       Date:  2006-05-25       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.